Pricing Log in Create free account

AEON Biopharma, Inc. (AEON) vs Vyome Holdings, Inc. (HIND)

AEON Biopharma, Inc. and Vyome Holdings, Inc. are both Biotechnology companies. Vyome Holdings, Inc. is the larger, with a market value of $11.4M against $9.4M — 1.2× the size. AEON Biopharma, Inc. has the higher net margin (0.00% vs −8,711.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, AEON Biopharma, Inc. leads on 5 and Vyome Holdings, Inc. on 5.

Valuation

Metric AEON HIND Biotechnology median
P/E n/m n/m 10.26
P/S n/m 87.06 9.18
P/B n/m 1.55 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 124.58 8.98
Earnings yield (2,762.50%) (222.25%) (34.89%)
Free cash flow yield (168.78%) (49.36%) (24.52%)

Profitability

Metric AEON HIND Biotechnology median
Gross margin — 52.77% 65.16%
Operating margin 0.00% (9,184.82%) 0.00%
Net margin 0.00% (8,711.71%) 0.00%
Free cash flow margin 0.00% (4,298.00%) 0.00%
Return on equity 350.00% (172.10%) (50.12%)
Return on assets (621.70%) (124.23%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AEON HIND Biotechnology median
Revenue growth (TTM) — (67.10%) 6.26%
EPS growth (last fiscal year) (105.42%) 99.92% 29.88%
Revenue growth, 5-year CAGR — (50.98%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AEON HIND Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.54 4.37 4.89
Net debt to EBITDA (2.48) 0.48 1.01

Dividend

Metric AEON HIND Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AEON HIND Biotechnology median
Market cap 9.35m 11.44m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack